News & Articles
Sepha introduces newly patented 3D leak detection technology for blister packs
The new technology incorporates a 3D sensor to provide volumetric measurement to assess the integrity of a range of pharmaceutical solid dose
Twist, Biotia introduce new NGS-based SARS-CoV-2 assay for research use
The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus
Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
PerkinElmer launches new HPLC, UHPLC and next-generation software solution
LC 300 platform and SimplicityChrom software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance
Lonza announces broad selection of high-resolution HLA-typed primary cell lots to support biologic drug research
The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization
DNASTAR releases Lasergene 17.2 software
Rigaku launches new curved single crystal X-ray diffraction detector with smaller form factor
The new HyPix-Arc 100 curved detector is based on direct X-ray detection technology, with a higher 20 range compared to a flat detector
Siemens Healthineers is the first leading diagnostics company offering a quantitative COVID-19 test to measure neutralizing antibodies
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working
QIAGEN launches NeuMoDx multiplex test to complete range of SARS-CoV-2 testing solutions in Europe and other markets
Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing
QIAGEN launches portable digital SARS-CoV-2 antigen test that can accurately analyze over 30 samples per hour
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes